World-Class Extractions Inc.
~ PED continues to provide solutions for licensed cannabis retailers with a collaboration with Buddi, a provider of technology solutions for licensed cannabis retailers across Canada
VANCOUVER, BC / ACCESSWIRE / August 10, 2021 / World-Class Extractions Inc. (CSE:PUMP)(FRA:WCF)(OTCQB:WCEXF) ("Company" or "World-Class"), is pleased to announce that its subsidiary, Pineapple Express Delivery Inc. ("Pineapple Express Delivery" or "PED"), a company in which World-Class has a controlling interest, continues to expand its technology footprint with a collaboration with Clearleaf Inc. (operating as "Buddi") to facilitate online sales and cannabis delivery services for licensed cannabis retailers.
Pineapple Express Delivery, in collaboration with Buddi, will provide integration of its CannDeliv technology, delivery program, support, access, and driver training services to Buddi's large network of 500 licensed cannabis retailers across Canada. The integration of PED's CannDeliv platform with Buddi's network will allow those licensed cannabis retailers served by Buddi to deliver its retail cannabis products efficiently and effectively to their customers.
Randy Rolph, CEO of Pineapple Express Delivery stated: "This collaboration with Buddi is exciting for PED as we continue to grow and expand across Canada and cannabis retailers continue to adapt to changing regulations. Consumers should be able to receive their products quickly and safely and as easily as they obtain other products in Canada. Integrating PED's technology with Buddi's online and e-commerce solutions provides retail customers a best-in-class experience when making online purchases through cannabis dispensaries utilizing Buddi's software platform."
Ryan Lalonde, CEO and Founder of Buddi stated: "This collaboration is a huge win for cannabis retailers who are looking to offer delivery in Canada. The integration between Buddi and PED will make it even easier for retailers to sell online, and to provide a fantastic delivery experience that's easy for both the store and customer."
PED's logistics and delivery services include medical and recreational cannabis delivery in Ontario, Manitoba, Saskatchewan - and now British Columbia - and liquor delivery in certain jurisdictions in Saskatchewan. Pineapple Express Delivery's clients include City Cannabis in BC, Shoppers Drug Mart / Medical Cannabis by Shoppers™, Spectrum Therapeutics, the medical division of Canopy Growth Corporation (TSX:WEED)(NYSE:CGC), The Saskatoon Co-operative Association Ltd. (Liquor Division) and CannTrust Inc. to their estora™ medical cannabis patients.
About Pineapple Express Delivery Inc.
Pineapple Express Delivery's management team has over 10 years of experience offering same-day 60-minute delivery services in multiple industries across Canada with a record breaking 40,000 deliveries per month, and completing 1-Million deliveries in early July 2021. Pineapple Express Delivery offers a personalized experience for its customers and has established in-depth security and delivery protocols to facilitate delivery of cannabis and alcohol in Canada. Pineapple Express Delivery has been providing a same day delivery option to the legal cannabis industry since October 17th, 2018. Pineapple Express Delivery is a subsidiary of World-Class Extractions Inc. For more information please visit https://pineappleexpressdelivery.com/.
About Buddi
Buddi is a Canadian technology company, based in Vancouver, BC, focused on in-store and online menus, cannabis e-commerce, and cannabis delivery software solutions for Canadian licensed cannabis retailers. Founded in 2017, Buddi serves over 500 licensed stores across Canada.
For further information about Buddi's services, visit www.buddi.io, or email info@buddi.io.
About World-Class
World-Class is an innovation-driven company with a focus on the evolving cannabis and hemp industries. World-Class offers compliant and secure delivery of government regulated products through its subsidiary Pineapple Express Delivery Inc., including medical and recreational cannabis in Ontario, Manitoba and Saskatchewan, and liquor delivery in certain jurisdictions in Saskatchewan. World-Class continues to investigate opportunities to deploy and manage custom-built extraction centres utilizing its custom systems, technology, and processes to efficiently produce high-quality cannabis and hemp concentrates and end-products.
Contact
World-Class Extractions Inc.
1-437-266-1968 | ir@worldclassextractions.com
www.worldclassextractions.com
https://pineappleexpressdelivery.com/
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this press release, which has been prepared by management.
Cautionary Note Regarding Forward-Looking Statements
All statements in this press release, other than statements of historical fact, are "forward-looking information" with respect to the Company within the meaning of applicable securities laws, and the ability of Pineapple Express Delivery to expand its delivery services and to provide discrete shipment of products. The Company provides forward-looking statements for the purpose of conveying information about current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. By its nature, this information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. These risks and uncertainties include but are not limited those identified and reported in the Company's public filings under the Company's SEDAR profile at www.sedar.com. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise unless required by law.
SOURCE: World-Class Extractions Inc.
View source version on accesswire.com:
https://www.accesswire.com/658977/Pineapple-Express-Delivery-Integrates-Technology-Solutions-for-Dispensary-Deliveries-with-Buddi-Collaboration
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESSWIRE
Subscribe to releases from ACCESSWIRE
Subscribe to all the latest releases from ACCESSWIRE by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESSWIRE
Opti Digital Breaks Down the Biggest AdTech Trends in 202518.10.2024 03:40:00 CEST | Press release
As the ad tech landscape evolves, 2025 promises to be a pivotal year for digital advertising, with key trends already emerging. BARCELONA, SPAIN / ACCESSWIRE / October 18, 2024 / Magali Quentel-Reme, CEO of Opti Digital; Mohsin Pervez, Senior Director of Platform Solutions and Operations, EMEA at PubMatic; and Langdon Miller, Director of Programmatic at Brainly, share their insights on the future of the AdTech landscape and the key trends set to shape programmatic in 2025. Addressability Solution With over 50% of third-party cookies already phased out and Google's pivotal July 2024announcement granting users control over cookie settings, the need for effective alternatives is more critical than ever. Langdon Miller, Director of Programmatic at Brainly, explains that "the integration of probabilistic and deterministic IDs, first-party data, contextual segmentation, and bid decoration has led to sustained performance and increased yield." This is echoed on the buy side, with a growing re
Participation in the Multilateral System Remains High as Performance Drops, New Index Finds17.10.2024 13:00:00 CEST | Press release
The Multilateralism Index 2024 reveals a contradiction: while participation in the multilateral system has largely held steady or even increased, its effectiveness in addressing global challenges has declined. WASHINGTON, DC / ACCESSWIRE / October 17, 2024 / Today marks the launch of the second edition of the Multilateralism Index from the International Peace Institute (IPI) and the Institute for Economics & Peace (IEP). The Index reveals that states remain engaged in the global multilateral system even as it increasingly struggles to address the crises it faces. Multilateralism Index 2024 Report An image of the front cover of the Multilateralism Index 2024 Report Key results The performance of the multilateral system declined across all five domains examined. Peace and security showed the steepest deterioration in performance, with the number of armed conflicts rising from 39 in 2013 to 55 in 2022. Climate action and human rights also saw significant declines in performance, despite i
Athos Announces Positive Topline Phase 1 Data for its AI-Generated, Novel, Oral G9A Inhibitor ATH-063, Demonstrating Selective Expansion and Activation of Potent Anti-Inflammatory Regulatory T Cells16.10.2024 09:00:00 CEST | Press release
ATH-063 significantly increased the number of circulating regulatory T cells (Tregs) across all doses and demonstrated enrichment in six well-described genes related to induced Treg anti-inflammatory activities No serious adverse effects or dose limiting toxicities were observed at any dose level, and ATH-063 demonstrated favorable pharmacokinetics (PK) The data provides clinical verification for Athos' Proprietary AI2 (Artificial Intelligence for Autoimmune drug development) computational software platform which generated ATH-063 LOS ANGELES, CA / ACCESSWIRE / October 16, 2024 / Athos Therapeutics, Inc. ("Athos"), a clinical stage biotechnology company pioneering the development of precision small molecule therapeutics for patients with immune-mediated diseases, today announced topline results for the company's Phase 1 clinical trial of ATH-063, an investigational oral small molecule G9A inhibitor and the company's lead asset in development for the treatment of inflammatory bowel dise
Probabl (The Official Operator of the Scikit-Learn Brand) Selects Kryterion to Provide Certification to Millions of Data Scientists in Machine Learning16.10.2024 08:40:00 CEST | Press release
HARROW, UK / ACCESSWIRE / October 16, 2024 / Kryterion, a leader in certification test development and delivery solutions, was selected by Probabl, the official operator of the scikit-learn brand, to deliver the first-ever official certification programme targeting millions of data scientists. The scikit-learn software library has registered over 1.5 billion downloads and is the gold standard for open-source machine learning in the Python ecosystem, underpinning over 1 million global projects. Kryterion's proven track record as a secure, scalable certification platform makes it the ideal partner for delivering this groundbreaking programme. Kryterion & Probabl Probabl and Kryterion will support the global data science community by offering the first globally recognised certification in scikit-learn. As the official operator of the scikit-learn brand, Probabl is spearheading the initiative to provide structured certification across three key tiers: associate, professional, and expert. T
Moolec Has Received USDA Approval for the First Genetically Modified Pea in History16.10.2024 06:00:00 CEST | Press release
LUXEMBOURG / ACCESSWIRE / October 16, 2024 / Moolec Science SA (NASDAQ:MLEC) ("the Company"), a leader in Molecular Farming technology, announced today that the U.S. Department of Agriculture's ("USDA") Animal and Plant Health Inspection Service ("APHIS") has completed its Regulatory Status Review ("RSR") for the Company's genetically engineered ("GE") peas which produce iron through bovine meat proteins. This is the third regulatory clearance from USDA-APHIS achieved by Moolec in an 18-month window, alongside its genetically engineered safflower and soybean for GLASO™ and Piggy Sooy™ products, respectively. Access the official USDA-APHIS publication here. "With USDA approval for our GE pea, Moolec has now secured regulatory clearance for all of our key crops in the US: safflower, soybean, and pea," said Gastón Paladini, CEO and Co-Founder of Moolec. "We are proud to be the only Molecular Farming company with three US regulatory approvals and a major commercial contract. This milestone
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom